Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Role of microglia in methamphetamine-induced neurotoxicity.

Xu E, Liu J, Liu H, Wang X, Xiong H.

Int J Physiol Pathophysiol Pharmacol. 2017 Jun 15;9(3):84-100. eCollection 2017. Review.

2.

Monoamine reuptake inhibitors in Parkinson's disease.

Huot P, Fox SH, Brotchie JM.

Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25. Review.

3.

Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.

Hou H, Wang C, Jia S, Hu S, Tian M.

Neurosci Bull. 2014 Oct;30(5):765-76. doi: 10.1007/s12264-014-1469-5. Epub 2014 Sep 28. Review.

4.

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Courtney KE, Ray LA.

Drug Alcohol Depend. 2014 Oct 1;143:11-21. doi: 10.1016/j.drugalcdep.2014.08.003. Epub 2014 Aug 17. Review.

5.

Cognitive judgment bias in the psychostimulant-induced model of mania in rats.

Rygula R, Szczech E, Kregiel J, Golebiowska J, Kubik J, Popik P.

Psychopharmacology (Berl). 2015 Feb;232(3):651-60. doi: 10.1007/s00213-014-3707-y. Epub 2014 Aug 14.

6.

Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).

Liu Y, Yue F, Tang R, Tao G, Pan X, Zhu L, Kung HF, Chan P.

Neurosci Bull. 2014 Jun;30(3):409-16. doi: 10.1007/s12264-013-1374-3. Epub 2013 Sep 5.

7.

Impact of methamphetamine on regional metabolism and cerebral blood flow after traumatic brain injury.

O'Phelan K, Ernst T, Park D, Stenger A, Denny K, Green D, Chang C, Chang L.

Neurocrit Care. 2013 Oct;19(2):183-91. doi: 10.1007/s12028-013-9871-9.

8.

Measuring "waiting" impulsivity in substance addictions and binge eating disorder in a novel analogue of rodent serial reaction time task.

Voon V, Irvine MA, Derbyshire K, Worbe Y, Lange I, Abbott S, Morein-Zamir S, Dudley R, Caprioli D, Harrison NA, Wood J, Dalley JW, Bullmore ET, Grant JE, Robbins TW.

Biol Psychiatry. 2014 Jan 15;75(2):148-55. doi: 10.1016/j.biopsych.2013.05.013. Epub 2013 Jun 19.

9.

Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects.

Jeong HS, Lee S, Yoon S, Jung JJ, Cho HB, Kim BN, Ma J, Ko E, Im JJ, Ban S, Renshaw PF, Lyoo IK.

Drug Alcohol Depend. 2013 Aug 1;131(3):222-9. doi: 10.1016/j.drugalcdep.2013.05.009. Epub 2013 Jun 12.

10.

Vesicular integrity in Parkinson's disease.

Alter SP, Lenzi GM, Bernstein AI, Miller GW.

Curr Neurol Neurosci Rep. 2013 Jul;13(7):362. doi: 10.1007/s11910-013-0362-3. Review.

11.

Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.

Groman SM, Jentsch JD.

Curr Opin Neurobiol. 2013 Aug;23(4):625-31. doi: 10.1016/j.conb.2013.03.001. Epub 2013 Mar 22.

12.

The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Afanador L, Mexhitaj I, Diaz C, Ordonez D, Baker L, Angulo JA.

Brain Res. 2013 May 13;1510:38-47. doi: 10.1016/j.brainres.2013.03.010. Epub 2013 Mar 19.

13.

Methamphetamine influences on brain and behavior: unsafe at any speed?

Marshall JF, O'Dell SJ.

Trends Neurosci. 2012 Sep;35(9):536-45. doi: 10.1016/j.tins.2012.05.006. Epub 2012 Jun 16. Review.

14.

Dysregulation of Dâ‚‚-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.

Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD.

J Neurosci. 2012 Apr 25;32(17):5843-52. doi: 10.1523/JNEUROSCI.0029-12.2012.

15.

Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.

Kufahl PR, Olive MF.

J Addict Res Ther. 2011 Nov 15;S1(3). pii: 003.

16.

Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.

Tulloch I, Ghazaryan N, Mexhitaj I, Ordonez D, Angulo JA.

Brain Res. 2011 Jul 5;1399:33-9. doi: 10.1016/j.brainres.2011.05.017. Epub 2011 May 15.

17.

Neuroimaging and drug taking in primates.

Murnane KS, Howell LL.

Psychopharmacology (Berl). 2011 Jul;216(2):153-71. doi: 10.1007/s00213-011-2222-7. Epub 2011 Mar 1. Review.

18.

Nonhuman primate positron emission tomography neuroimaging in drug abuse research.

Howell LL, Murnane KS.

J Pharmacol Exp Ther. 2011 May;337(2):324-34. doi: 10.1124/jpet.108.136689. Epub 2011 Feb 11.

19.

Dopamine is not essential for the development of methamphetamine-induced neurotoxicity.

Yuan J, Darvas M, Sotak B, Hatzidimitriou G, McCann UD, Palmiter RD, Ricaurte GA.

J Neurochem. 2010 Aug;114(4):1135-42. doi: 10.1111/j.1471-4159.2010.06839.x. Epub 2010 Jun 1.

20.

Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals.

Schwartz DL, Mitchell AD, Lahna DL, Luber HS, Huckans MS, Mitchell SH, Hoffman WF.

Neuroimage. 2010 May 1;50(4):1392-401. doi: 10.1016/j.neuroimage.2010.01.056. Epub 2010 Jan 22.

Supplemental Content

Support Center